# Comparison of Rabeprazole and Esomperazole for the Eradication of H. Pylori

> **NCT02767479** · PHASE3 · COMPLETED · sponsor: **Hamamatsu University** · enrollment: 200 (actual)

## Conditions studied

- H. Pylori Infection

## Interventions

- **DRUG:** rabeprazole-based regimen
- **DRUG:** esomeprazole^based regimen

## Key facts

- **NCT ID:** NCT02767479
- **Lead sponsor:** Hamamatsu University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-07
- **Primary completion:** 2016-04
- **Final completion:** 2016-04
- **Target enrollment:** 200 (ACTUAL)
- **Last updated:** 2017-06-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02767479

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02767479, "Comparison of Rabeprazole and Esomperazole for the Eradication of H. Pylori". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02767479. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*